Shares of Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) have earned an average rating of "Moderate Buy" from the six ratings firms that are currently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation, two have given a buy recommendation and two have assigned a strong buy recommendation to the company.
A number of brokerages recently commented on STVN. TD Cowen raised Stevanato Group to a "strong-buy" rating in a research report on Wednesday, June 17th. Weiss Ratings cut Stevanato Group from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Thursday, July 2nd. Finally, Wolfe Research started coverage on Stevanato Group in a research note on Tuesday, June 2nd. They issued an "outperform" rating and a $21.00 price objective for the company.
View Our Latest Stock Analysis on STVN
Stevanato Group Trading Down 4.4%
NYSE:STVN opened at €19.21 on Friday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.11 and a current ratio of 1.63. The firm has a market cap of $5.82 billion, a price-to-earnings ratio of 32.57, a price-to-earnings-growth ratio of 1.85 and a beta of 0.78. Stevanato Group has a 52 week low of €12.89 and a 52 week high of €28.00. The firm has a 50-day moving average price of €18.24 and a two-hundred day moving average price of €17.08.
Stevanato Group (NYSE:STVN - Get Free Report) last posted its earnings results on Friday, May 8th. The company reported €0.11 EPS for the quarter, missing the consensus estimate of €0.12 by (€0.01). Stevanato Group had a return on equity of 10.27% and a net margin of 11.76%.The firm had revenue of €273.57 million for the quarter. During the same quarter in the prior year, the company posted $0.10 earnings per share. The firm's quarterly revenue was up 6.6% on a year-over-year basis. On average, equities analysts expect that Stevanato Group will post 0.68 earnings per share for the current fiscal year.
Insider Activity at Stevanato Group
In related news, Director Madhavan Balachandran sold 1,493 shares of the business's stock in a transaction dated Monday, June 15th. The shares were sold at an average price of €17.09, for a total value of €25,515.37. Following the transaction, the director directly owned 69,458 shares of the company's stock, valued at approximately €1,187,037.22. The trade was a 2.10% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Donald E. Morel, Jr. sold 1,493 shares of the stock in a transaction dated Monday, June 15th. The shares were sold at an average price of €17.09, for a total transaction of €25,515.37. Following the transaction, the director owned 37,424 shares of the company's stock, valued at approximately €639,576.16. The trade was a 3.84% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 5,972 shares of company stock valued at $102,061 over the last quarter. Corporate insiders own 0.70% of the company's stock.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently modified their holdings of the stock. Handelsbanken Fonder AB raised its holdings in shares of Stevanato Group by 26.4% in the 2nd quarter. Handelsbanken Fonder AB now owns 30,600 shares of the company's stock worth $553,000 after purchasing an additional 6,400 shares during the period. First Bank & Trust lifted its stake in Stevanato Group by 3.4% in the second quarter. First Bank & Trust now owns 18,417 shares of the company's stock valued at $333,000 after purchasing an additional 603 shares during the last quarter. Cooper Investors PTY Ltd. grew its holdings in Stevanato Group by 4.4% during the second quarter. Cooper Investors PTY Ltd. now owns 668,494 shares of the company's stock valued at $12,080,000 after purchasing an additional 28,265 shares during the period. Confluence Investment Management LLC bought a new position in Stevanato Group during the second quarter valued at $6,062,000. Finally, Glenmede Trust Co. NA increased its position in Stevanato Group by 29.5% in the first quarter. Glenmede Trust Co. NA now owns 38,461 shares of the company's stock worth $529,000 after buying an additional 8,770 shares during the last quarter.
About Stevanato Group
(
Get Free Report)
Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.
In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Stevanato Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.
While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.